The 2010 Physician Payments Sunshine Act requires public reporting of industry payments to physicians and teaching hospitals in the United States. Since its passage, the association between receipt of payments and increased prescribing of higher-cost medications has been repeatedly demonstrated. The full impact of these payments remains unclear, however, because the Sunshine Act did not apply to prescribers who were not physicians. In 2022, that will change. A provision, “Fighting the Opioid Epidemic with Sunshine,”1 of a 2018 federal law expands public reporting of industry payments to include nurse practitioners, physician assistants, certified nurse midwives, certified nurse anesthetists, and clinical nurse specialists.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
DeJong C, Steinbrook R. Shining a Light on Industry Payments to Health Care Professionals Who Are Not Physicians. JAMA Intern Med. Published online June 10, 2019. doi:10.1001/jamainternmed.2019.1367
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: